Cambridge Healthtech Institute’s 6th Annual

Managing Late Stage Research and Observational Studies  

Strategies and Technologies to Enable Non-Interventional Studies
January 24-26, 2017 | Hyatt Regency Miami | Miami, FL


Dear Colleague:

I am pleased to announce production of CHI’s 6th Annual “Managing Late Stage Research and Observational Studies: Strategies and Technologies to Enable Non-Interventional Studies” being held January 24-25, 2017 at the Hyatt Regency in Miami, FL.

The gathering will be part of the 8th Annual Summit for Clinical Trials Operations Executives (SCOPE), a three-day cluster of events that attracted 1,150 leaders in clinical operations and research in February 2016. Topics to be discussed at the “Managing Late Stage Research and Observational Studies” conference include:

  • The purposes and the value of late stage and observational trials
  • Building an effective healthcare outcome study
  • Combining safety, efficacy and pharmacoeconomics endpoints
  • Complement registration package with real world data
  • Operational similarities and differences with clinical trials
  • Prospective vs retrospective trials
  • Harnessing the power of existing databases
  • Development of a companywide, cross functional long-term strategic business goals and objectives for post-marketing studies
  • Site selection and feasibility assessment in post-marketing studies
  • Monitoring post-marketing studies: specific features and requirements
  • Physician and patient retention in long term observational studies
  • Managing outsourced observational studies
  • Patient-centered technologies in post-marketing studies
  • How to initiate an observational study
  • Social networks, digital media and PROs in pharmacovigilance research
  • Meeting regulatory requirements for post-authorization in various countries and regions

If you are interested in presenting, please click here.

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic/hospital centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Deadline for submission is June 15, 2016.

2017 SCOPE Conference at a Glance

SCOPE 2016 Wrap-Up

The 7th Annual SCOPE Summit, held February 23-25, 2016 in Miami, Florida, had record attendance with more than 1,150 industry leaders joining 3 days of in-depth discussions covering important issues in clinical trial planning and management. As SCOPE grew in attendance by 30% over last year, the 2016 program offered 12 distinct conference tracks, 2 symposia, 3 short courses, and 4 plenary keynote sessions, focused on advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials.

For Further Information

For questions or suggestions about the meeting, please contact:

Marina Filshtinsky, M.D.
Senior Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5496
E: mfilshtinsky@healthtech.com

For partnering and sponsorship information, please contact:

Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com